VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo)
PsychRounds: The Psychiatry Podcast · Dr. Tanner Hewitt, Dr. Larry Wang and Dr. Bradley Miller
21. marts 2026 17m
0:00 17m
Beskrivelse
Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo). References: https://pubmed.ncbi.nlm.nih.gov/41626799/ https://www.ncbi.nlm.nih.gov/books/NBK548187/ https://pubmed.ncbi.nlm.nih.gov/41626799/
